Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 499,734 |
|
|||||
| News | (1) | ||||||
| Day High | 0.7715 | Low High |
|||||
| Day Low | 0.70 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| PaxMedica Inc | PXMD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0258 | 3.66% | 0.73 | 23:00:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.705 | 0.70 | 0.7715 | 0.7398 | 0.7042 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,107 | 499,734 | US$ 0.7386924 | US$ 369,150 | - | 0.372 - 29.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:57:29 | 85 | US$ 0.73 | USD |
PaxMedica Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.48M | 7.41M | - | 0 | -18.29M | -2.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
PaxMedica News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PXMD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7329 | 0.85 | 0.677 | 0.7318781 | 463,803 | -0.0029 | -0.40% |
| 1 Month | 0.53 | 1.189 | 0.4011 | 0.7995751 | 7,251,600 | 0.20 | 37.74% |
| 3 Months | 0.5004 | 1.189 | 0.372 | 0.7833066 | 2,582,751 | 0.2296 | 45.88% |
| 6 Months | 5.5267 | 10.26 | 0.372 | 2.05 | 2,983,694 | -4.80 | -86.79% |
| 1 Year | 25.84 | 29.75 | 0.372 | 3.85 | 1,816,524 | -25.11 | -97.17% |
| 3 Years | 110.50 | 178.16 | 0.372 | 26.63 | 1,854,297 | -109.77 | -99.34% |
| 5 Years | 110.50 | 178.16 | 0.372 | 26.63 | 1,854,297 | -109.77 | -99.34% |
PaxMedica Description
| PaxMedica Inc an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism spectrum disorder (or ASD), and Fragile X syndrome tremor-ataxia (or FXTAS). It focuses on the development and testing of its lead program, PAX-101, an intravenous formulation of suramin, in the treatment of ASD and FXTAS. It is also focused on the treatment of Human African Trypanosomiasis (or HAT). Its candidate PAX-102, proprietary intranasal formulation of suramin, as well as other new chemical entities that are more targeted and highly selective antagonists of particular purinergic receptor subtypes. |
